Cipla Oseltamivir 75 mg Capsules.
PDF Leaflet Revision Date: 20 May 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment and prophylaxis of influenza.
Dosage (summary)
Adults: 75 mg twice daily for 5 days; Children: weight-based dosing.
Onset of Action / Duration
Onset: 30 mins, Duration: 6-8 hours
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
- Immunocompromised patients
Pregnancy & Breastfeeding
Safety not established; avoid breastfeeding during treatment.
Key Drug Interactions
- Cimetidine
- Probenecid
- Amoxicillin
- Paracetamol
Contraindications
- Hypersensitivity to oseltamivir
Common side effects
- Nausea
- Vomiting
- Headache
Counselling Points
- Take with or without food
- Monitor for neuropsychiatric symptoms
- Not a substitute for vaccination
Serious warnings
- Neuropsychiatric events reported
- Monitor for abnormal behavior
Important Disclaimer
The Cipla Oseltamivir 75 mg Capsules. professional information leaflet below is the property of Cipla Medpro and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
